PRIGNANO, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.352
EU - Europa 3.197
AS - Asia 667
OC - Oceania 6
SA - Sud America 6
AF - Africa 3
Totale 8.231
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.330
PL - Polonia 1.100
IT - Italia 607
IE - Irlanda 600
SE - Svezia 428
HK - Hong Kong 301
CN - Cina 155
RU - Federazione Russa 132
JO - Giordania 72
DE - Germania 71
FI - Finlandia 68
SG - Singapore 67
GB - Regno Unito 58
UA - Ucraina 52
CH - Svizzera 40
TR - Turchia 28
CA - Canada 22
VN - Vietnam 18
IN - India 16
FR - Francia 12
BE - Belgio 11
NL - Olanda 8
AR - Argentina 6
AU - Australia 6
ES - Italia 5
KR - Corea 5
IR - Iran 4
EG - Egitto 2
SM - San Marino 2
AT - Austria 1
IQ - Iraq 1
MU - Mauritius 1
NO - Norvegia 1
RO - Romania 1
Totale 8.231
Salva come PNG Salva come JPEG
Città #
Warsaw 1.098
Dublin 597
Fairfield 569
Chandler 547
Lawrence 273
Altamura 272
Woodbridge 272
Ashburn 258
Wilmington 214
Cambridge 209
Seattle 207
Houston 197
Princeton 173
Buffalo 170
Hong Kong 159
Medford 148
Ann Arbor 108
San Diego 92
Jacksonville 82
Moscow 79
Beijing 59
Shanghai 51
Boston 46
Norwalk 43
Singapore 43
Bern 35
Boardman 35
Kent 31
Florence 30
Rome 29
Izmir 26
Toronto 19
Andover 17
Milan 17
Hillsboro 12
New York 12
Brussels 11
Dearborn 10
Dong Ket 8
Los Angeles 8
Phoenix 8
Prescot 8
London 7
Buenos Aires 6
Laurel 6
Padova 6
Palermo 6
Falls Church 5
Nanjing 5
Seoul 5
Tappahannock 5
Verona 5
Bremen 4
Düsseldorf 4
Hanover 4
Pistoia 4
Redwood City 4
Saint Petersburg 4
Washington 4
Acquaviva Picena 3
Agrigento 3
Arona 3
Bologna 3
Cagliari 3
Chennai 3
El Paso 3
Ft. Washington 3
Guangzhou 3
Hefei 3
Kilburn 3
Kunming 3
Magnago 3
Montelupo Fiorentino 3
Montepulciano 3
Naples 3
Napoli 3
Redmond 3
Reggio Emilia 3
San Mateo 3
Adelaide 2
Arezzo 2
Arnsberg 2
Bani Suwayf 2
Barcelona 2
Buttigliera Alta 2
Castelnuovo di Garfagnana 2
Catania 2
Cento 2
Chiari 2
Dallas 2
Delhi 2
Düdingen 2
Farra di Soligo 2
Gozzano 2
Luton 2
Messina 2
Montecorice 2
Montegranaro 2
Munich 2
Naaldwijk 2
Totale 6.468
Salva come PNG Salva come JPEG
Nome #
Lesioni cutanee «specifiche» in corso di leucemia linfatica cronica. 432
CD30+ cutaneous T-cell lymphoma associated with sarcoidosis 241
Altered redox status in the blood of psoriatic patients: involvement of NADPH oxidase and role of anti-TNF-α therapy 231
Immunophenotypical markers, ultrastructure and chemosensitivity profile of metastatic melanoma cells. 227
The involvement of Smac/DIABLO, p53, NF-kB and MAPK pathways in apoptosis of keratinocytes from perilesional vitiligo skin: protective effects of curcumin and capsaicin 223
SIRT1 regulates MAPK pathways in vitiligo skin: insight into the molecular pathways of cell survival 213
Serial QuantiFERON TB-Gold in-tube testing during LTBI therapy in candidates for TNFi treatment 201
Ultrastructural and functional alterations of mitochondria in perilesional vitiligo skin. 183
Efalizumab in the treatment of psoriasis: when comorbidity is an issue. 144
New and experimental treatments of vitiligo and other hypomelanoses. 137
Prurigo nodularis and lichen simplex chronicus. 134
The importance of genetical link in immuno-mediated dermatoses: psoriasis and vitiligo. 125
Comparison of body weight and clinical-parameter changes following the treatment of plaque psoriasis with biological therapies. 117
A rational approach to the treatment of vitiligo and other hypomelanoses. 113
Vogt-Koyanagi-Harada disease and vitiligo: where does the illness begin? 107
Fibroblasts to keratinocytes redox signaling: The possible role of ROS in psoriatic plaque formation 106
Retrospective analysis of systemic treatments for psoriasis patients attending a Psocare center in Florence. Relevance of biological drugs use and comorbidities. 104
Treatment of Psoriasis with Efalizumab in Patients with Hepatitis C Viral Infection: Report of Five Cases. 100
Psoriasis and body mass index. 91
Circulating dendritic cell subsets in psoriatic patients before and after biologic therapy 89
Unusual presentation of tuberculosis in an infliximab-treated patient--which is the correct TB screening before starting a biologic? 88
Efalizumab-induced severe thrombocytopenia can be resolved. 82
Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa 82
Morphologic and antigenic features of dendritic cells in immune-mediated dermatoses: A hypothesis of differentiation 80
Secukinumab reduces plasma oxidative stress in psoriasis: A case-based experience 79
Therapeutical approaches in melasma. 78
Cutaneous sarcoidosis during rituximab treatment for microscopic polyangiitis: An uncommon adverse effect? 75
Sequential effects of photodynamic treatment of basal cell carcinoma 74
Protease-activated receptor-2 downregulation is associated to vitiligo lesions 73
The concept of psoriatic disease: can cutaneous psoriasis any longer be separated by the systemic comorbidities? 73
Bullous pemphigoid: Italian guidelines adapted from the EDF/EADV guidelines 72
In-vivo imaging of psoriatic lesions with polarization multispectral dermoscopy and multiphoton microscopy 72
Interleukin 22 early affects keratinocyte differentiation, but not proliferation, in a three-dimensional model of normal human skin. 71
The role of the dermatologist in Raynaud's Phenomenon: a clinical challenge 70
Quantity, distribution and immunophenotypical modification of dendritic cells upon biological treatments in psoriasis. 67
Mast cells do not play a role in vitiligo 64
Evidence for oxidative stress in the plasma of psoriatic patients: Source of ROS and results of treatments with biologics 64
Lichen planus triggered by CT-P13 and recurrence during secukinumab treatment 61
Latent tuberculosis infection in patients with chronic plaque psoriasis: Evidence from the Italian Psocare Registry 61
Scabies: should we always perform dermatoscopy? 59
Induction of CD83+ CD14+ non-dendritic antigen-presenting cells by exposure of monocytes to IFN-alpha1 53
A mesenchyme-derived substrate is necessary for keratinocytes differentiation but not proliferation (Abs. 148). 47
NADPH Oxidase 4 as a Source of Oxidative Stress in Fibroblasts From Patients Affected by Psoriasis 44
Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions 43
Alpha-smooth muscle actin axpression by fibroblasts is not a marker of hypertrophic scars in vitro (Abs. 774). 42
Mental health consequences of the covid-19 pandemic long-term exposure in italian dermatologists 42
Clinical experience with adalimumab biosimilar imraldi in hidradenitis suppurativa 42
Clinical evaluation of topical tacalcitol efficacy in extending the remission period between nb-UVB phototherapy cycles in psoriatic patients. 41
Curcumin and capsaicin prevent mitochondrial damage and apoptosis in keratinocytes from perilesional vitiligo skin 40
Source of oxidative stress in fibroblasts from patients affected by psoriasis 40
Hidradenitis suppurativa and adalimumab in the COVID-19 era 39
Atypical mycobacteria 39
Smooth-muscle actin, desmin and prolyl 4-hydroxylase in fibroblasts grown from hypertrophic scars and keloids (Abs. 99). 38
Clinical experience with infliximab biosimilar in psoriasis 38
Guselkumab: an anti-IL-23 antibody for the treatment of moderate-to-severe plaque psoriasis 38
Clinical characteristics of psoriasis in inflammatory bowel disease patients 38
Comment on “Oral lichenoid reaction in a psoriatic patient treated with secukinumab: A drug-related rather than a class-related adverse event?” 38
Tuscan consensus on the diagnosis, treatment and follow-up of moderate-to-severe psoriasis 38
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study 38
Involvement of PAR-2 in vitiligo 37
COVID-19 and psoriasis: Should we fear for patients treated with biologics? 37
Cutaneous hyperpigmentation induced by apremilast 37
Effects of cyclosporin-A on the morphology of human Langerhans cells in cultured epidermal sheets Abs. 7). 36
Latent tuberculosis infection in psoriasis and other dermatological immunomediated diseases: a combined approach by QuantiFERON-TB Gold and tuberculin skin tests. 36
Vitiligo masks malignant acanthosis nigricans in a woman with ovarian cancer 36
High frequency ultrasound can detect improvement of lesions in juvenile localized scleroderma 36
The Kinetics of Antidrug Antibodies, Drug Levels, and Clinical Outcomes in Infliximab-Exposed Patients with Immune-Mediated Disorders 36
Treatment of psoriasis with topical agents: Recommendations from a Tuscany Consensus 36
SB5 adalimumab biosimilar in the treatment of psoriasis and psoriatic arthritis 36
Patient satisfaction with calcipotriol/betamethasone dipropionate cutaneous foam for the treatment of plaque psoriasis: The LION real-life multicenter prospective observational cohort study 36
Clinical experience with the etanercept biosimilar SB4 in psoriatic patients 36
Photodynamic therapy and apoptosis in cutaneous basal cell carcinoma (Abs 002). 35
Effects of GM-CSF and TNF-alpha on the Langerhans cells of human epidermal sheets (Abs. 827). 35
Reduction in psoriasis related pruritus during biologic therapy* 35
Oxidative stress in the pathogenesis of vitiligo 34
Cutaneous 'desmoplastic' B-cell lymphoma 34
Mitochondrial Damage and Apoptosis in Keratinocytes from Perilesional Vitiligo Skin: Protective Effects of Curcumin and Capsaicin 34
Etanercept biosimilar SB4 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry 34
PAR-2 is downregulated in keratinocytes from vitiligo lesions. 33
Factors influencing number and differentiation of Langerhans cells within epidermis (Abs P9). 33
Ultrastructural mitochondrial alterations and oxidative damage in keratinocytes from perilesional vitiligo skin 33
Possible reconsideration of the Nail Psoriasis Severity Index (NAPSI) score 33
Epidemiology of Psoriasis and Psoriatic Arthritis in Italy—a Systematic Review 33
Anti-tumor necrosis factor agents in psoriasis: addressing key challenges using biosimilars 33
Vitiligo: Ultrastructure, oxidative stress and apoptosis in perilesional skin 32
Ultrasound detects occult entheseal involvement in early psoriatic arthritis independently of clinical features and psoriasis severity. 32
Granulocyte macrophage-colony stimulating factor augments the functional activity of LC in vitro. 32
A pediatric case of sclerodermatous graft-versus-host disease responsive to ultraviolet A1 phototherapy 32
First case of secukinumab successful therapy in a very elderly psoriatic patient 32
Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study 32
Safety and efficacy of HCV eradication during etanercept treatment for severe psoriasis 32
Oxidative stress markers in psoriatic patients plasma and NADPH oxidase as a source of oxidative stress in fibroblasts 31
Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice 31
Prevalence of alexithymia in patients with psoriasis and its association with disease burden: a multicentre observational study 31
Sister Mary Joseph node 31
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study 31
Ultrastructural study of the effect of proinflammatory cytokines in a three‐dimensional model of normal human skin. 30
Tumor necrosis factor-alpha and interleukin-17 differently affects Langerhans cell distribution and activation in an innovative three-dimensional model of normal human skin 30
Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: Results from the Italian Psocare Registry 30
Ultrasonographic wrist and hand abnormalities in early psoriatic arthritis patients: Correlation with clinical, dermatological, serological and genetic indices 30
Totale 6.914
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.530
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.530
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.253 104 94 43 94 146 134 153 167 119 83 92 24
2020/2021795 69 69 53 65 33 107 35 68 73 100 56 67
2021/20221.239 32 60 47 29 6 100 184 87 64 40 325 265
2022/20232.748 291 680 127 178 154 491 324 98 238 16 71 80
2023/2024921 37 81 185 43 36 64 49 215 18 76 75 42
2024/2025120 120 0 0 0 0 0 0 0 0 0 0 0
Totale 8.361